Johnson & Johnson: Pharmaceutical and medical-device giant.
Price
270.36
24H
—
Volume 24h
$87.62K
OI (USD)
$474.04K
Market Cap
$648.86B
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
 | JNJUSDT | 270.72 | 269.61 | +41.2 bps | +0.00% +0.0000% / 8h · -- | $60.52K | 69.1% | $141.87K | 50d |
 | JNJ-USDT-SWAP | 269.66 | 269.52 | +5.2 bps | +0.00% +0.0000% / 8h · -- | $21.27K | 24.3% | $113.31K | 79d |
 | JNJ_USDT | 269.15 | 269.01 | +5.2 bps | +0.00% +0.0000% / 8h · -- | $5.82K | 6.6% | $218.85K | 153d |
News
10JNJ▲Johnson & Johnson Orthopaedics Reportedly Draws Apollo Interest, Potential Deal Valued at $20 Billion
8dJNJ▲FDA clears Stelara for use in children with ulcerative colitis
25dJNJ▲J&J's targeted oral peptide drug Aiteya® approved in China for moderate-to-severe plaque psoriasis
26dJNJ▲FDA approves J&J's Imaavy as first-ever treatment for warm AIHA in patients 12+
29d